The Company Behind the Clinic Boom

The easiest way to misunderstand ICBD is to call it a holding company and move on. That label is technically useful and practically incomplete. From its Fort Lauderdale base, the privately held firm owns and supports a portfolio concentrated in healthcare, behavioral health, and technology. But its real product is less visible: a ready-made layer of executives, recruiters, lawyers, technologists, marketers, financial operators, and real-estate specialists who can enter a young business before that business could plausibly hire such a bench for itself.

ICBD calls itself a business incubator and a single family office. Its initials double as a house motto - “It Can Be Done.” The message is blunt, almost cheerfully Floridian. Founders arrive with an idea or an early company; ICBD supplies what usually takes years to assemble. The promise is not a quarterly workshop or a thick advisory deck. It is people inside the operation, doing the work.

The clearest demonstration is ABA Centers, the autism-care provider launched in 2020. ICBD says the network now reaches more than 75 service markets across the United States and its territories. The growth was built de novo, through opening locations rather than buying an existing national chain. Every pin on that map therefore represents a lease, a construction schedule, a clinical hiring effort, credentialing, technology, marketing, billing, and a door that eventually had to open on time.

The back office becomes the front line

In ordinary corporate language, finance, HR, IT, legal, and facilities are “support functions.” ICBD turns that hierarchy sideways. In a regulated, labor-intensive field, these functions determine whether the service exists at all. A clinic without clinicians is a decorated room. A clinician without credentialing cannot bill. A claim without clean data becomes delayed revenue. A promising market without a viable building remains a spreadsheet cell.

That is ICBD's point of difference. Venture capital supplies money and networks. Private equity often supplies capital, governance, and acquisition discipline. A consultancy supplies recommendations. ICBD combines ownership with an embedded operating platform. Its public description divides that platform into six parts: operators; enterprise IT and data; finance and legal; talent and HR; brand and growth; and real estate and operations.

The list sounds tidy. The advantage comes from the handoffs. A growth team can identify a city; real estate can find a site; finance can model it; legal can paper it; talent can staff it; IT can connect it; marketing can fill the intake funnel. The work is sequential, but the institutional memory compounds. A second clinic should be less mysterious than the first. By the twentieth, opening day can start to resemble a practiced routine.

What separates a fledgling company from a category leader isn't capital - it's expertise, talent, and infrastructure.ICBD's description of its operating thesis

A family problem becomes a platform test

Founder Christopher M. Barnett has connected ABA Centers' origin to his family's difficulty getting the right care for his autistic daughter. The problem was not abstract: delayed diagnosis, long waiting lists, and families losing time during a consequential stage of childhood. The business response was to shorten the path into care. ABA Centers has said it typically aims to move a child from initial contact into active therapy in 47 days, compared with waits that can run for months.

That goal reveals why the model is operational rather than merely financial. Demand is not the same as access. A waiting list proves that people want a service; it does not create the clinicians, appointments, authorizations, or rooms required to deliver it. ICBD's job is to attack those bottlenecks together. Its growth team reported taking ABA Centers from eight clinics in three states to more than 50 markets in 12 states during an earlier expansion phase. The current company site places the footprint above 75 markets.

The numbers attracted notice. ABA Centers entered the 2024 Inc. 5000 at No. 5 after reporting 32,192 percent three-year revenue growth. It ranked No. 1 on the Financial Times list of the Americas' fastest-growing companies in 2025, then No. 25 on the 2025 Inc. 5000. In 2026 it placed No. 15 on Inc.'s Southeast regional list, its third straight regional appearance. Barnett also received EY's 2024 U.S. National Overall Entrepreneur Of The Year award.

Awards are snapshots, not clinical outcomes. Still, they validate one part of the thesis: the operating machine can produce speed. ICBD's harder, longer test is whether the same machine can preserve quality, staff cohesion, and patient trust as the map fills in. Healthcare scale is full of friction that does not appear on a growth chart.

One engine, several vehicles

ABA Centers is the flagship, not the whole fleet. Exact Billing Solutions handles medical revenue-cycle management and consulting. GateHouse Treatment provides addiction treatment designed around long-term recovery. MAT Care Clinics focuses on medication-assisted treatment for alcohol and opioid addiction. ICBD also presents a concierge primary-care and pediatrics business, the Christopher M. Barnett Family Foundation, and Curative AI, an emerging healthcare technology venture.

The collection can look scattered until one notices the shared constraints. These are service businesses where access, staffing, compliance, billing, and trust matter. Their customers differ: families seeking autism services, people in recovery, physicians trying to collect what they are owed, patients who want more direct access to a doctor. The infrastructure underneath them can overlap.

That overlap is the business model. ICBD has not published its ownership percentages, fee structure, consolidated revenue, or valuation. Publicly, it describes a privately held family office that invests in and builds companies, then provides the central capacity to grow them. The economic logic is straightforward even without the missing figures: build or own valuable operating businesses, make shared expertise reusable, and participate in the long-term value those companies create.

The culture of an imperative

“It Can Be Done” is less a mission statement than an answer delivered before the meeting is over. ICBD pairs it with three values: accountability, service, and excellence. Its careers material promises a startup's pace with the resources of a much larger institution. Benefits include a 6 percent 401(k) match, tuition reimbursement, and, for selected clinical workers, a full master's scholarship through Temple University.

The Temple relationship is unusually circular. Barnett first gave $1 million in 2022 to establish the ABA Centers Autism Lab, which conducts research, trains students, and offers diagnostic services. In 2025 he committed $55 million to Temple, the largest gift in the university's history; $20 million was designated for the autism lab. The partnership touches the same shortage the company encounters in the market: trained people. Philanthropy, workforce development, research, and care delivery sit in the same loop.

There is another sign that the story is entering a new chapter. ABA Centers, self-funded during its early expansion, publicly began looking for a strategic growth partner to help reach more states. Curative AI, meanwhile, extends the platform toward software and data. Both moves ask whether ICBD's operating method can travel - into a larger capital structure, into technology, and eventually into companies it did not originate.

The most interesting thing ICBD sells is competence before a young company could afford to build it.YesPress analysis

Within the market, ICBD occupies an awkward and useful middle. It is more operational than a conventional family office, more permanent than a consulting engagement, and broader than a single healthcare provider. Competitors range from venture studios and healthcare private-equity firms to other operating holding companies. At the portfolio level, the alternatives are more concrete: national autism providers, addiction-treatment networks, billing vendors, and an expanding field of healthcare AI companies.

For a founder, the practical appeal is easy to steal: stop treating the boring functions as chores to be postponed. Design them as a system. Connect recruiting to real estate, technology to billing, and marketing to capacity. For ICBD, the next proof will not be another spectacular percentage. It will be whether the system keeps producing companies whose service improves as their footprint grows. The clinic boom made ICBD visible. The operating discipline behind it is what makes the company consequential.